WINTON MATTHEW (COO) received a stock award from INOZYME PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2024ACC: 0000950170-24-041300
+3.19K
Net shares
Net buyer
$10.6K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.19K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.19K
Price / share
$3.33
Trade value
$10.62K
% of position
New position
3/28/2024
0.00→3.19K
Total
Net shares
+3.19K
Net value
$10.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/28/2024 | A · Award | +3.19K | $3.33 | $10.62K | New position | 0.00 | 3.19K |
| Total | +3.19K | $10.62K | ||||||
Derivative Transactions0
No derivative transactions reported